Medical Oncology and Haemato-Oncology Programmes

The NCCP National Medical Oncology and Haemato-oncology Programmes aim to ensure that the needs of the anticipated increased incidence in cancer diagnosis and requirements for treatment continue to be met.  The national Medical Oncology and Haemato-oncology Programmes incorporates a number of initiatives aimed at coordinating and managing cancer drug services, ensuring appropriate access to and monitoring of cancer drug use and ensuring that appropriate forward-planning is undertaken to meet future requirements.

Information on the work of the programmes is available by clicking the links on the left and below.

Cancer Drug Management Programme

Clinical Trials 

Contact the National Medical Oncology and Haemato-oncology Programmes

Dose Banding for Systemic Anticancer Therapy

Haemato-oncology Patient Pathways

Molecular Diagnostics (Drugs) Advisory Group

National Meeting

NCCP Systemic Anti-Cancer Therapy Model of Care

NCCP Technology Review Committee

National Cancer Information System (NCIS)

Oncology Medication Safety Review

Peptide Receptor Radionuclide Therapy (PRRT)

SACT Guidance, Documents and Resources